Global Rotavirus Vaccine Market Insight 2020, Forecast to 2030
- Report Code : WOR1772389
- Published On: Jun, 2020
- Category : Healthcare & Pharma
- Pages : 130
-
The Rotavirus Vaccine market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Rotavirus Vaccine is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Rotavirus Vaccine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Rotavirus Vaccine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Rotavirus Vaccine market are discussed.
The market is segmented by types:
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
It can be also divided by applications:
Hospital
Vaccination Station
Other
And this report covers the historical situation, present status and the future prospects of the global Rotavirus Vaccine market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.
Finally, the report provides detailed profile and data information analysis of leading company.
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
Report Includes:
- xx data tables and xx additional tables
- An overview of global Rotavirus Vaccine market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Rotavirus Vaccine market
- Profiles of major players in the industry, including GSK, Sanofi-Pasteur, Merck, Biological E. Limited, China National Biotec Group..
Research objectives
To study and analyze the global Rotavirus Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Rotavirus Vaccine market by identifying its various subsegments.
Focuses on the key global Rotavirus Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
To analyze the Rotavirus Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rotavirus Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
-
With tables and figures helping analyze worldwide Global Rotavirus Vaccine market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Rotavirus Vaccine Market Report 2020, Forecast to 2025
1 Scope of the Study1.1 Rotavirus Vaccine Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Rotavirus Vaccine Industry Overview2.1 Global Rotavirus Vaccine Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Rotavirus Vaccine Global Import Market Analysis
2.1.2 Rotavirus Vaccine Global Export Market Analysis
2.1.3 Rotavirus Vaccine Global Main Region Market Analysis2.2 Market Analysis by Type
2.2.1 Rotarix
2.2.2 RotaTeq
2.2.3 Rotavac
2.2.4 Rotavin-M1
2.2.5 Lanzhou lamb2.3 Market Analysis by Application
2.3.1 Hospital
2.3.2 Vaccination Station
2.3.3 Other2.4 Global Rotavirus Vaccine Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Rotavirus Vaccine Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Rotavirus Vaccine Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Rotavirus Vaccine Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Rotavirus Vaccine Manufacturer Market Share
2.4.5 Top 10 Rotavirus Vaccine Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Rotavirus Vaccine Market
2.4.7 Key Manufacturers Rotavirus Vaccine Product Offered
2.4.8 Mergers & Acquisitions Planning2.5 Rotavirus Vaccine Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Rotavirus Vaccine Industry Impact
2.7.1 How the Covid-19 is Affecting the Rotavirus Vaccine Industry
2.7.2 Rotavirus Vaccine Business Impact Assessment - Covid-19
2.7.3 Market Trends and Rotavirus Vaccine Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 Upstream and Downstream Market Analysis3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Rotavirus Vaccine Manufacturing Cost Analysis3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Rotavirus Vaccine Market Size Categorized by Regions4.1 Global Rotavirus Vaccine Revenue, Sales and Market Share by Regions
4.1.1 Global Rotavirus Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Rotavirus Vaccine Revenue and Market Share by Regions (2015-2020)4.2 Europe Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.3 APAC Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.4 North America Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Rotavirus Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5 Europe Rotavirus Vaccine Market Size Categorized by Countries5.1 Europe Rotavirus Vaccine Sales, Revenue and Market Share by Countries
5.1.1 Europe Rotavirus Vaccine Sales by Countries (2015-2020)
5.1.2 Europe Rotavirus Vaccine Revenue by Countries (2015-2020)
5.1.3 Germany Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.1.4 UK Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.1.5 France Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.1.6 Russia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.1.7 Italy Rotavirus Vaccine Sales and Growth Rate (2015-2020)
5.1.8 Spain Rotavirus Vaccine Sales and Growth Rate (2015-2020)5.2 Europe Rotavirus Vaccine Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Rotavirus Vaccine Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Rotavirus Vaccine Sales Market Share by Type (2015-2020)
5.3.2 Europe Rotavirus Vaccine Revenue and Revenue Share by Type (2015-2020)5.4 Europe Rotavirus Vaccine Sales Market Share by Application (2015-2020)
6 Asia-Pacific Rotavirus Vaccine Market Size Categorized by Countries6.1 Asia-Pacific Rotavirus Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Rotavirus Vaccine Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Rotavirus Vaccine Revenue by Countries (2015-2020)
6.1.3 China Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.1.4 Japan Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.1.5 Korea Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.1.6 India Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Rotavirus Vaccine Sales and Growth Rate (2015-2020)
6.1.8 Australia Rotavirus Vaccine Sales and Growth Rate (2015-2020)6.2 Asia-Pacific Rotavirus Vaccine Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Rotavirus Vaccine Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Rotavirus Vaccine Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Rotavirus Vaccine Revenue and Revenue Share by Type (2015-2020)6.4 Asia-Pacific Rotavirus Vaccine Sales and Market Share by Application (2015-2020)
7 North America Rotavirus Vaccine Market Size Categorized by Countries7.1 North America Rotavirus Vaccine Sales, Revenue and Market Share by Countries
7.1.1 North America Rotavirus Vaccine Sales by Countries (2015-2020)
7.1.2 North America Rotavirus Vaccine Revenue by Countries (2015-2020)
7.1.3 United States Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.1.4 Canada Rotavirus Vaccine Sales and Growth Rate (2015-2020)
7.1.5 Mexico Rotavirus Vaccine Sales and Growth Rate (2015-2020)7.2 North America Rotavirus Vaccine Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Rotavirus Vaccine Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Rotavirus Vaccine Sales Market Share by Type (2015-2020)
7.3.2 North America Rotavirus Vaccine Revenue and Revenue Share by Type (2015-2020)7.4 North America Rotavirus Vaccine Sales Market Share by Application (2015-2020)
8 South America Rotavirus Vaccine Market Size Categorized by Countries8.1 South America Rotavirus Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Rotavirus Vaccine Sales by Countries (2015-2020)
8.1.2 South America Rotavirus Vaccine Revenue by Countries (2015-2020)
8.1.3 Brazil Rotavirus Vaccine Sales and Growth Rate (2015-2020)8.2 South America Rotavirus Vaccine Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Rotavirus Vaccine Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Rotavirus Vaccine Sales Market Share by Type (2015-2020)
8.3.2 South America Rotavirus Vaccine Revenue and Revenue Share by Type (2015-2020)8.4 South America Rotavirus Vaccine Sales Market Share by Application (2015-2020)
9 Middle East and Africa Rotavirus Vaccine Market Size Categorized by Countries9.1 Middle East and Africa Rotavirus Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Rotavirus Vaccine Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Rotavirus Vaccine Revenue by Countries (2015-2020)
9.1.3 GCC Countries Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.1.4 Turkey Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.1.5 Egypt Rotavirus Vaccine Sales and Growth Rate (2015-2020)
9.1.6 South Africa Rotavirus Vaccine Sales and Growth Rate (2015-2020)9.2 Middle East and Africa Rotavirus Vaccine Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Rotavirus Vaccine Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Rotavirus Vaccine Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Rotavirus Vaccine Revenue and Revenue Share by Type (2015-2020)9.4 Middle East and Africa Rotavirus Vaccine Sales Market Share by Application (2015-2020)
10 Global Rotavirus Vaccine Market Segment by Type10.1 Global Rotavirus Vaccine Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Rotavirus Vaccine Sales and Market Share by Type (2015-2020)
10.1.2 Global Rotavirus Vaccine Revenue and Market Share by Type (2015-2020)10.2 Rotarix Sales Growth Rate and Price
10.2.1 Global Rotarix Sales Growth Rate (2015-2020)
10.2.2 Global Rotarix Price (2015-2020)10.3 RotaTeq Sales Growth Rate and Price
10.3.1 Global RotaTeq Sales Growth Rate (2015-2020)
10.3.2 Global RotaTeq Price (2015-2020)10.4 Rotavac Sales Growth Rate and Price
10.4.1 Global Rotavac Sales Growth Rate (2015-2020)
10.4.2 Global Rotavac Price (2015-2020)10.5 Rotavin-M1 Sales Growth Rate and Price
10.5.1 Global Rotavin-M1 Sales Growth Rate (2015-2020)
10.5.2 Global Rotavin-M1 Price (2015-2020)10.6 Lanzhou lamb Sales Growth Rate and Price
10.6.1 Global Lanzhou lamb Sales Growth Rate (2015-2020)
10.6.2 Global Lanzhou lamb Price (2015-2020)
11 Global Rotavirus Vaccine Market Segment by Application11.1 Global Rotavirus VaccineSales Market Share by Application (2015-2020)
11.2 Hospital Sales Growth Rate (2015-2020)
11.3 Vaccination Station Sales Growth Rate (2015-2020)
11.4 Other Sales Growth Rate (2015-2020)
12 Market Forecast for Rotavirus Vaccine12.1 Global Rotavirus Vaccine Revenue, Sales and Growth Rate (2020-2025)
12.2 Rotavirus Vaccine Market Forecast by Regions (2020-2025)
12.2.1 Europe Rotavirus Vaccine Market Forecast (2020-2025)
12.2.2 APAC Rotavirus Vaccine Market Forecast (2020-2025)
12.2.3 North America Rotavirus Vaccine Market Forecast (2020-2025)
12.2.4 South America Rotavirus Vaccine Market Forecast (2020-2025)
12.2.5 Middle East & Africa Rotavirus Vaccine Market Forecast (2020-2025)12.3 Rotavirus Vaccine Market Forecast by Type (2020-2025)
12.3.1 Global Rotavirus Vaccine Sales Forecast by Type (2020-2025)
12.3.2 Global Rotavirus Vaccine Market Share Forecast by Type (2020-2025)12.4 Rotavirus Vaccine Market Forecast by Application (2020-2025)
12.4.1 Global Rotavirus Vaccine Sales Forecast by Application (2020-2025)
12.4.2 Global Rotavirus Vaccine Market Share Forecast by Application (2020-2025)
13 Analysis of Rotavirus Vaccine Industry Key Manufacturers13.1 GSK
13.1.1 Company Details
13.1.2 Product Information
13.1.3 GSK Rotavirus Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 GSK News13.2 Sanofi-Pasteur
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Sanofi-Pasteur Rotavirus Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Sanofi-Pasteur News13.3 Merck
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Merck Rotavirus Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Merck News13.4 Biological E. Limited
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Biological E. Limited Rotavirus Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Biological E. Limited News13.5 China National Biotec Group
13.5.1 Company Details
13.5.2 Product Information
13.5.3 China National Biotec Group Rotavirus Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 China National Biotec Group News13.6 Sinovac Biotech
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Sinovac Biotech Rotavirus Vaccine Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Sinovac Biotech News
14 Research Findings and Conclusion
15 Appendix
-
The Global Rotavirus Vaccine Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Companies in the Global Rotavirus Vaccine Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
Global Rotavirus Vaccine has a wide range of applications, including
It is expected that the Global Rotavirus Vaccine Market will reach USD XX million by 2029.
The Global Rotavirus Vaccine Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
In this highly competitive and rapidly evolving Global Rotavirus Vaccine Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.